Skip to main content
E

EnsoData

EnsoData offers EnsoSleep, a cloud-based platform that utilizes waveform artificial intelligence to automate the scoring and reporting of polysomnography (PSG) and home sleep apnea tests (HSAT). This technology reduces the time required for sleep study analysis by an average of 62%, enabling clinicians to focus on patient care and improve operational efficiency in sleep disorder diagnosis and treatment.

Madison, United StatesFounded 2015595K+ followers
Updated 19 months ago

Funding

$31.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

IM
Funding rounds are not available yet.

Founders

Product

Problem

Sleep labs and healthcare systems face challenges in efficiently and accurately scoring polysomnography (PSG) and home sleep apnea tests (HSAT), leading to delays in diagnosis and treatment of sleep disorders. Manual scoring methods are time-consuming and can create backlogs, limiting the number of patients that can be served.

Solution

EnsoData offers EnsoSleep, a cloud-based software platform that leverages waveform artificial intelligence (AI) to automate the viewing, scoring, editing, and reporting of PSGs and HSATs. The platform streamlines the sleep testing process, accelerating both in-lab and at-home test analysis. By automating the scoring process, EnsoSleep reduces the time required for sleep study analysis, allowing clinicians to focus on patient care and other revenue-generating procedures. The interoperable platform can be accessed from any device, standardizing data acquisition and scoring quality across multiple lab locations.

Target Audience

The primary customers are hospitals, health systems, independent sleep labs, and durable medical equipment (DME) providers seeking to optimize their sleep care continuum, improve operational efficiency, and enhance patient care.

Features

  • AI-powered automated scoring of PSGs and HSATs, trained on over 1,750,000 sleep studies scored by registered sleep technologists (RPSGTs)
  • Cloud-based platform accessible from any device, facilitating remote access and collaboration
  • Study management platform to expedite clinical actions across devices, locations, and teams
  • Integration with EnsoSleep PPG and Celeste+ mobile application for data collection and transfer from pulse oximeters
  • Remote Physiological Monitoring (RPM) capabilities for CPAP titration and monitoring patient therapy data
  • Advanced metrics, including Hypoxic Burden, to provide a deeper understanding of OSA severity and potential cardiovascular risks
  • ePrescribing functionality
This profile is AI-generated and may contain inaccuracies.